The Centers for Disease Control and Prevention are offering a research grant to evaluate the effectiveness of influenza vaccines against laboratory-confirmed influenza-associated hospitalizations in the US. This grant focuses on measuring the impact of vaccines in preventing severe cases of influenza, contributing to public health strategies.
Opportunity ID: 291755
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-15-00203CONT17 |
| Funding Opportunity Title: | Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations |
| Opportunity Category: | Continuation |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 10 |
| Assistance Listings: | 93.083 — Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Feb 12, 2017 |
| Last Updated Date: | Mar 14, 2017 |
| Original Closing Date for Applications: | Mar 22, 2017 |
| Current Closing Date for Applications: | Apr 03, 2017 |
| Archive Date: | Apr 21, 2017 |
| Estimated Total Program Funding: | $0 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | This award will be a continuation of funds intended only for grantees previously awarded under RFA-IP-15-002: Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Centers for Disease Control and Prevention (CDC)
Office of Grant Services (OGS) Technical Information Management Section (TIMS) Phone: 770-488-2700 Email:ogstims@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| PER GMO, REVISED DUE DATE | Mar 14, 2017 | |
| CFDA number | Mar 14, 2017 | |
| Feb 12, 2017 |
DISPLAYING: Synopsis 3
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-15-00203CONT17 |
| Funding Opportunity Title: | Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations |
| Opportunity Category: | Continuation |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 10 |
| Assistance Listings: | 93.083 — Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Feb 12, 2017 |
| Last Updated Date: | Mar 14, 2017 |
| Original Closing Date for Applications: | Mar 22, 2017 |
| Current Closing Date for Applications: | Apr 03, 2017 |
| Archive Date: | Apr 21, 2017 |
| Estimated Total Program Funding: | $0 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | This award will be a continuation of funds intended only for grantees previously awarded under RFA-IP-15-002: Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Centers for Disease Control and Prevention (CDC)
Office of Grant Services (OGS) Technical Information Management Section (TIMS) Phone: 770-488-2700 Email:ogstims@cdc.gov |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-15-00203CONT17 |
| Funding Opportunity Title: | Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations |
| Opportunity Category: | Continuation |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 10 |
| Assistance Listings: | 93.083 — Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Mar 14, 2017 |
| Last Updated Date: | Feb 12, 2017 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Mar 22, 2017 |
| Archive Date: | Apr 21, 2017 |
| Estimated Total Program Funding: | $0 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | This award will be a continuation of funds intended only for grantees previously awarded under RFA-IP-15-002: Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Centers for Disease Control and Prevention (CDC)
Office of Grant Services (OGS) Technical Information Management Section (TIMS) Phone: 770-488-2700 Email:ogstims@cdc.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-15-00203CONT17 |
| Funding Opportunity Title: | Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations |
| Opportunity Category: | Continuation |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 10 |
| Assistance Listings: | 93.185 — Immunization Research, Demonstration, Public Information and Education_Training and Clinical Skills Improvement Projects |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 12, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Mar 22, 2017 |
| Archive Date: | Apr 21, 2017 |
| Estimated Total Program Funding: | $0 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | This award will be a continuation of funds intended only for grantees previously awarded under RFA-IP-15-002: Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Centers for Disease Control and Prevention (CDC)
Office of Grant Services (OGS) Technical Information Management Section (TIMS) Phone: 770-488-2700 Email:ogstims@cdc.gov |
Related Documents
Folder 291755 Full Announcement-RFA-IP-15-00203CONT17 -> RFA-IP-15-00203CONT17.pdf
Packages
| Agency Contact Information: | Centers for Disease Control and Prevention (CDC) Office of Grant Services (OGS) Technical Information Management Section (TIMS) Phone: 770-488-2700 Email: ogstims@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.185 | NCIRD-R-C | Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations | PKG00230789 | Feb 12, 2017 | Apr 03, 2017 | View |
Package 1
Mandatory forms
291755 RR_SF424_2_0-2.0.pdf
291755 PHS398_CoverPageSupplement_3_0-3.0.pdf
291755 PerformanceSite_2_0-2.0.pdf
291755 RR_Budget_1_4-1.4.pdf
291755 RR_KeyPersonExpanded_2_0-2.0.pdf
291755 PHS398_ResearchPlan_3_0-3.0.pdf
291755 RR_OtherProjectInfo_1_3-1.3.pdf
Optional forms
291755 PHS_Inclusion_Enrollment_Report-1.0.pdf
291755 RR_SubawardBudget30_1_4-1.4.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
